02509

13.0106.87%
WL

Weidong Lin

Deputy GM & Executive Director

Mr. Weidong Lin was appointed as Qyuns Therapeutics Co., Ltd.’s Director on March 16, 2022 and was re-designated as Qyuns Therapeutics Co., Ltd.’s Executive Director on March 23, 2023. Mr. Lin joined Qyuns Therapeutics Co., Ltd. and its subsidiaries in August 2021 and served as the Vice President of Finance of Qyuns Therapeutics Co., Ltd. from August 2021 to September 2021. He has been serving as the Deputy General Manager of Qyuns Therapeutics Co., Ltd. since September 2021. Mr. Lin is experienced in auditing and corporate financial management. Prior to joining Qyuns Therapeutics Co., Ltd. and its subsidiaries, Mr. Lin served as an Auditor at Shanghai De’An Certified Public Accountants from October 2004 to June 2005 and worked at KPMG Huazhen LLP (Shanghai Branch) from November 2005 to December 2009 with his last position being an assistant Audit Manager. Since 2010, Mr. Lin has accumulated extensive experience in corporate financial management by serving as the senior management at various enterprises, including as: (i) a Financial Manager of Shanghai Arkema Gaoyuan Chemical Co., Ltd., a company primarily engaged in production of high quality engineering polyamides and a subsidiary of Arkema S. A., a specialty chemicals and advanced materials company whose shares are listed on Euronext Paris, from May 2010 to May 2012, where he was primarily responsible for the overall financial management; (ii) a regional financial Manager for Asia Pacific operation at Imerys (Shanghai) Investment Management Co., Ltd. and Imerys (Shanghai) Filtering Minerals Trading Co., Ltd., both of which are primarily engaged in non-metallic minerals processing and trading and are subsidiaries of Imerys S. A., a specialty minerals company whose shares are listed on Euronext Paris, from December 2013 to June 2015; (iii) a Vice President of Finance at Shanghai Muhe Network Technology Co., Ltd., from February 2016 to October 2016; (iv) the Co-Founder and Chief Financial Officer at Ifenqu Network Technology Shanghai Co., Ltd., from November 2016 to March 2018; (v) worked at Shanghai Yiguo E-commerce Co., Ltd., from September 2018 to March 2019; and (vi) a Financial Director at Harbour BioMed (Shanghai) Co., Ltd., from June 2019 to December 2020. Mr. Lin received a bachelor’s degree in English from Tongji University in the PRC in July 2004 and a master’s degree in business administration (MBA) from Shanghai Jiao Tong University in the PRC in June 2016. He was qualified as a Certified Public Accountant non-practicing Member by The Chinese Institute of Certified Public Accountants in February 2013.

Positions